VRNA Wutah pendapatan kuartal marang kuartal veronapharma.com

Simbol resmi perusahaan Verona Pharma plc (VRNA)

The quarterly revenue growth trend demonstrates how the indicator value reaches 0.00. This positive momentum is driven by the product launch stage and the exclusive right to determine therapy pricing. FDA protection against drug copying and patent purity ensure high profitability. Consequently, Verona Pharma plc (VRNA) is strengthening its status as an authoritative developer in the treatment of respiratory pathologies.

VRNA Tingkat wutah pendapatan sajrone kuartal Verona Pharma Corp (04.07.2022 - 18.10.2025)

Ringkesan rincian data analitis Verona Pharma Corp (VRNA)

- rega saham lan target rega konsensus:
- data saldo dhuwit lan arus kas:
Analisis umum perusahaan:VRNA - Verona Pharma Corp
Produk sing diprodhuksi Verona Pharma PLC

Fundamental revenue analysis allows investors to minimize risks by identifying the actual trajectory of business development. For Verona Pharma plc (VRNA), the effectiveness of ESG strategies and the optimization of drug supply chains must translate into actual cash flow. This quarterly revenue trend metric measures the percentage change in income over three months relative to the previous period. A stable growth trend confirms the company's capitalization and the resilience of its market positions.

Pesaing wigati

HLN - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal kenvue.com|Jyong Bio (MENS) - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur Ligand LGND|AMRX (amneal.com) - Wutah pendapatan triwulanan|PRGO: Tambahing pendapatan triwulanan|Wutah dodolan triwulanan ALVO (Alvotech Corp)|Tingkat wutah dodolan sajrone kuartal Liquidia Corporation|Wutah pendapatan triwulanan GLPG (glpg.com)|Tambahing pendapatan triwulanan ANIP|MNKD - Wutah pendapatan kuartal marang kuartal|Amphastar - Owah-owahan dodolan kuartal marang kuartal|PCRX: Wutah pendapatan triwulanan|ars-pharma.com - Tambahing pendapatan triwulanan|TBPH (Theravance Biopharma Inc) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aquestive Pharma AQST|Wutah pendapatan triwulanan SCPH|Owah-owahan dodolan kuartal marang kuartal TECX|Wutah pendapatan kuartal marang kuartal tonixpharma.com TNXP|SXTC (SXT China) - Dinamika pendapatan kuartal marang kuartal|Eupraxia Pharmaceuticals - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal BioHarvest Sciences Inc. BHST|EXOZ: Wutah pendapatan triwulanan|Oramed (ORMP) - Wutah pendapatan triwulanan|ENTX (Entera Bio) - Wutah pendapatan triwulanan|ipatherapeutics.com (HYFT) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Tingkat wutah pendapatan sajrone kuartal|TELO: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Wutah pendapatan kuartal marang kuartal|RLYB - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Lexaria Bioscience|Pulmatrix Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal ftzy.com.cn (PTHL)|Aptorum Group - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan LYRA (Lyra Therapeutics Inc.)|Tingkat wutah dodolan sajrone kuartal Impact BioMedical (IBO)|TNF Pharmaceuticals - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal cbdMD Inc.|PainReform Ltd. (PRFX) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Altamira Therapeutics (CYTO)|Wutah pendapatan kuartal marang kuartal Lipella Pharmaceuticals, Inc.|OPTN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Pieris (PIRS)|Wutah pendapatan triwulanan Procaps Group Corp (PROC)|Wutah pendapatan triwulanan PTPI (petrospharma.com)|Tambahing pendapatan triwulanan QLI|ACELYRIN - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan TFFP (TFF Pharmaceuticals Inc.)